Leading firms’ generic sales growth are stable
Published: 2010-04-26 06:59:00
Updated: 2010-04-26 06:59:00
Domestic leading drugmakers have enjoyed strong returns, thanks much to increasing market demand. Industry sources expect sales will rise consistently, and Korean drug firms will continue to make a soft landing into the generic markets.
Korean firms have made gains in generic versions of Plavi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
